Literature DB >> 28161832

Enhanced biosafety of silica coated gadolinium based nanoparticles.

Marta Laranjeira1,2,3, Yuki Shirosaki4, Saki Yoshimatsu Yasutomi4, Toshiki Miyazaki5, Fernando Jorge Monteiro6,7,8.   

Abstract

One of the most important and novel approaches of biomedical engineering is the development of new, effective and non-invasive medical diagnosis abilities, and treatments that have such requirements as advanced technologies for tumor imaging. Gadolinium (Gd) compounds can be used as MRI contrast agents, however the release of Gd3+ ions presents some adverse side effects such as renal failure, pancreatitis or local necrosis. The main aim of the work was the development and optimization of Gadolinium based nanoparticles coated with silica to be used as bioimaging agent. Gd based nanoparticles were prepared through a precipitation method and afterwards, these nanoparticles were covered with silica, using Stöber method with ammonia and functionalized with 3-Aminopropyltriethoxysilane (APTES). Results showed that nanoparticles were homogeneous regarding chemical composition, silica layer thickness, total size and morphology. Also, silica coating was successfully not degraded after 4 weeks at pH 5.5, 6.0 and 7.4, contrary to GdOHCO3 nanoparticles that degraded. Regarding the in vitro cell tests, very good cell proliferation and viability were observed. In conclusion, the results showed that Gd based nanoparticles coated with silica for imaging applications were successfully obtained under a well-controlled method. Furthermore, silica coating may enhance magnetic nanoparticles biosafety because it avoids GdOHCO3 degradation into harmful products (such as Gd3+ ions) at physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28161832     DOI: 10.1007/s10856-017-5855-1

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  11 in total

1.  Characterization of in vitro genotoxic, cytotoxic and transcriptomic responses following exposures to amorphous silica of different sizes.

Authors:  Nathalie Decan; Dongmei Wu; Andrew Williams; Stéphane Bernatchez; Michael Johnston; Myriam Hill; Sabina Halappanavar
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2015-11-25       Impact factor: 2.873

Review 2.  The therapeutic application of lanthanides.

Authors:  Simon P Fricker
Journal:  Chem Soc Rev       Date:  2006-04-28       Impact factor: 54.564

Review 3.  Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.

Authors:  Harutaka Mekaru; Jie Lu; Fuyuhiko Tamanoi
Journal:  Adv Drug Deliv Rev       Date:  2015-10-03       Impact factor: 15.470

4.  Control of shell thickness in silica-coating of Au nanoparticles and their X-ray imaging properties.

Authors:  Yoshio Kobayashi; Hiromitsu Inose; Tomohiko Nakagawa; Kohsuke Gonda; Motohiro Takeda; Noriaki Ohuchi; Atsuo Kasuya
Journal:  J Colloid Interface Sci       Date:  2011-01-22       Impact factor: 8.128

Review 5.  Maturation of white matter in the human brain: a review of magnetic resonance studies.

Authors:  T Paus; D L Collins; A C Evans; G Leonard; B Pike; A Zijdenbos
Journal:  Brain Res Bull       Date:  2001-02       Impact factor: 4.077

6.  Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.

Authors:  Yi-Xiang J Wang
Journal:  Quant Imaging Med Surg       Date:  2011-12

7.  Gadolinium(III)-Chelated Silica Nanospheres Integrating Chemotherapy and Photothermal Therapy for Cancer Treatment and Magnetic Resonance Imaging.

Authors:  Mingjing Cao; Pengyang Wang; Yu Kou; Jing Wang; Jing Liu; Yanhui Li; Jiayang Li; Liming Wang; Chunying Chen
Journal:  ACS Appl Mater Interfaces       Date:  2015-11-06       Impact factor: 9.229

8.  FITC-Dextran entrapped and silica coated gadolinium oxide nanoparticles for synchronous optical and magnetic resonance imaging applications.

Authors:  Shailja Kumar; Virendra Kumar Meena; Puja Panwar Hazari; Rakesh Kumar Sharma
Journal:  Int J Pharm       Date:  2016-03-23       Impact factor: 5.875

9.  A cancer-recognizable MRI contrast agents using pH-responsive polymeric micelle.

Authors:  Kyoung Sub Kim; Wooram Park; Jun Hu; You Han Bae; Kun Na
Journal:  Biomaterials       Date:  2013-10-15       Impact factor: 12.479

10.  Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.

Authors:  Soo Min Kim; Geun Ho Im; Dong-Gyu Lee; Jung Hee Lee; Won Jae Lee; In Su Lee
Journal:  Biomaterials       Date:  2013-08-21       Impact factor: 12.479

View more
  2 in total

Review 1.  Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.

Authors:  Cristina Chircov; Angela Spoială; Cătălin Păun; Luminița Crăciun; Denisa Ficai; Anton Ficai; Ecaterina Andronescu; Ștefan Claudiu Turculeƫ
Journal:  Molecules       Date:  2020-08-21       Impact factor: 4.411

2.  Evaluation of Microwave Ablation in 4T1 Breast Tumor by a Novel VEFGR2 Targeted Ultrasound Contrast Agents.

Authors:  Xiaoyu Li; Shujun Xia; Ri Ji; Weiwei Zhan; Wei Zhou
Journal:  Front Oncol       Date:  2021-07-20       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.